index

CJC-1295/Ipamorelin

  • Regular price $80.00

Hurrify, 11080 item(s) left in stock!

Join Waitlist

CJC-1295 and Ipamorelin are often combined as peptide therapy to boost growth hormone (GH) production, offering synergistic effects. Below are the key benefits of this combination:

1.  Increased Muscle Mass and Strength: Stimulates protein synthesis and nitrogen retention, promoting muscle growth and enhancing physical performance, ideal for athletes or those seeking improved body composition.

2.  Fat Loss: Accelerates lipolysis (fat breakdown) and boosts metabolism, helping reduce body fat, especially in stubborn areas.

3.  Improved Recovery: Enhances tissue repair and regeneration, speeding up recovery from workouts, injuries, or joint pain.

4.  Better Sleep Quality: Regulates circadian rhythms, leading to deeper, more restorative sleep, which supports overall recovery and GH production.

5.  Anti-Aging Effects: Increases collagen production and improves skin elasticity, reducing visible signs of aging. May also support cognitive function, memory, and mental clarity.

6.  Enhanced Energy and Vitality: Elevates energy levels and stamina, combating age-related fatigue.

7.  Improved Insulin Sensitivity: May reduce triglycerides and blood sugar levels, supporting metabolic health.

8.  Stronger Immune and Cardiovascular Systems: Boosts immune function and may improve heart health by supporting better lipid profiles.

How It Works: CJC-1295, a growth hormone-releasing hormone (GHRH) analog, extends GH release duration, while Ipamorelin, a ghrelin mimetic, rapidly triggers GH pulses. Together, they amplify GH secretion 3-5 times more than either alone, with CJC-1295’s 6-8 day half-life and Ipamorelin’s 2-hour half-life ensuring both immediate and sustained effects.

- No EU import duties.
- Ships within 1-2 business days.
- Ships in our fully recyclable and biodegradable signature boxes.

Fast shipping
Secure payment

CJC-1295/Ipamorelin - 5MG

$80.00

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)

Recently viewed